Trial NCT04402866; EudraCT 2020-001807-18
Publication Singh D, medRxiv (2021) (preprint)
Primary outcome on the report: Safety and tolerability, pharmacokinetics, and oxygen saturation/fraction of inspired oxygen ratio; clinical outcomes were also explored

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.